GB201320959D0 - Compositions - Google Patents

Compositions

Info

Publication number
GB201320959D0
GB201320959D0 GBGB1320959.8A GB201320959A GB201320959D0 GB 201320959 D0 GB201320959 D0 GB 201320959D0 GB 201320959 A GB201320959 A GB 201320959A GB 201320959 D0 GB201320959 D0 GB 201320959D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1320959.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLOBALACORN Ltd
Original Assignee
GLOBALACORN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GLOBALACORN Ltd filed Critical GLOBALACORN Ltd
Priority to GBGB1320959.8A priority Critical patent/GB201320959D0/en
Publication of GB201320959D0 publication Critical patent/GB201320959D0/en
Priority to CN201480071119.6A priority patent/CN106163561A/en
Priority to AU2014356250A priority patent/AU2014356250A1/en
Priority to EP14806369.6A priority patent/EP3074042A1/en
Priority to US15/039,750 priority patent/US20160354402A1/en
Priority to PCT/GB2014/053522 priority patent/WO2015079241A1/en
Priority to CA2935083A priority patent/CA2935083A1/en
Priority to JP2016534964A priority patent/JP2017502930A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1320959.8A 2013-11-27 2013-11-27 Compositions Ceased GB201320959D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1320959.8A GB201320959D0 (en) 2013-11-27 2013-11-27 Compositions
CN201480071119.6A CN106163561A (en) 2013-11-27 2014-11-27 Compositions
AU2014356250A AU2014356250A1 (en) 2013-11-27 2014-11-27 Compositions
EP14806369.6A EP3074042A1 (en) 2013-11-27 2014-11-27 Compositions
US15/039,750 US20160354402A1 (en) 2013-11-27 2014-11-27 Compositions
PCT/GB2014/053522 WO2015079241A1 (en) 2013-11-27 2014-11-27 Compositions
CA2935083A CA2935083A1 (en) 2013-11-27 2014-11-27 Compositions
JP2016534964A JP2017502930A (en) 2013-11-27 2014-11-27 Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1320959.8A GB201320959D0 (en) 2013-11-27 2013-11-27 Compositions

Publications (1)

Publication Number Publication Date
GB201320959D0 true GB201320959D0 (en) 2014-01-08

Family

ID=49918302

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1320959.8A Ceased GB201320959D0 (en) 2013-11-27 2013-11-27 Compositions

Country Status (8)

Country Link
US (1) US20160354402A1 (en)
EP (1) EP3074042A1 (en)
JP (1) JP2017502930A (en)
CN (1) CN106163561A (en)
AU (1) AU2014356250A1 (en)
CA (1) CA2935083A1 (en)
GB (1) GB201320959D0 (en)
WO (1) WO2015079241A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312039B (en) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 A kind of preparation method of tenofovir prodrug

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462028B2 (en) * 1997-07-25 2002-10-08 Inspire Pharmaceuticals, Inc. Method of promoting cervical and vaginal secretions
CN100354296C (en) * 1998-10-02 2007-12-12 雅玛山酱油株式会社 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same and method forproducing said compound
MXPA02005161A (en) * 1999-12-22 2002-12-09 Inspire Pharmaceuticals Inc Method of treating gastrointestinal tract disease with purinergic receptor agonists.
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
WO2003039473A2 (en) * 2001-11-06 2003-05-15 Inspire Pharmaceuticals, Inc. Method for treating or preventing inflammatory diseases
EP1348466A3 (en) * 2002-02-01 2003-10-29 Inspire Pharmaceuticals, Inc. Method for treating pain with adenosine-tetraphosphates
FR2842424A1 (en) * 2002-07-22 2004-01-23 Univ Paris 7 Denis Diderot USE OF NAD OR ONE OF ITS ANALOGS, SUBSTRATE OF MONO-ADP-RIBOSYL TRANFERASES, FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CONDITIONS RELATED TO PURINERGIC RECEPTORS
GB0502250D0 (en) * 2005-02-03 2005-03-09 Ic Vec Ltd Use

Also Published As

Publication number Publication date
CA2935083A1 (en) 2015-06-04
US20160354402A1 (en) 2016-12-08
CN106163561A (en) 2016-11-23
AU2014356250A1 (en) 2016-07-07
JP2017502930A (en) 2017-01-26
WO2015079241A1 (en) 2015-06-04
EP3074042A1 (en) 2016-10-05

Similar Documents

Publication Publication Date Title
GB201304662D0 (en) Compositions
PL3065569T4 (en) Composition
EP2889350A4 (en) Tacky-adhesive composition
GB201313615D0 (en) Compositions
HK1214088A1 (en) Oil\fat composition
PL3027750T3 (en) Biocatalytical composition
EP3006525A4 (en) Asphalt-urethane composition
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
GB201306984D0 (en) Composition
EP3066178A4 (en) Lumbricant composition
GB201322772D0 (en) Composition
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201316463D0 (en) Novel compositions
ZA201505650B (en) New compositions
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201320962D0 (en) Compositions
GB201318394D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)